Advertisement

International Journal of Clinical Pharmacy

, Volume 37, Issue 4, pp 636–644 | Cite as

Experiences of community pharmacists advising pregnant women

  • Švitrigailė GrincevičienėEmail author
  • Loreta Kubilienė
  • Kostas Ivanauskas
  • Gražina S. Drąsutienė
  • Diana Ramašauskaitė
  • Jonas Grincevičius
  • Jurga Bernatonienė
  • Arūnas Savickas
Research Article

Abstract

Background Recent studies have shown that pharmacists provide healthcare advice to pregnant women, and that they can play an important role in maternal care. However, pharmacists have faced challenges in advising mothers and coordinating with physicians. Objective To explore the experiences of community pharmacists in advising pregnant women at Lithuanian community pharmacies. Setting Community pharmacies in Lithuania. Methods Community pharmacists (n = 27) were recruited for semistructured face-to-face interviews from June 2012 to March 2013. A qualitative and descriptive study based on the content analysis approach was used for data collection and analysis. Main outcome measure Thematic coding of Lithuanian community pharmacist interview content. Results Three main areas emerged: topics of advice-giving, provision of information, and barriers to advice-giving. The question of whether to interact with the physician connected to all of these areas. Pharmacists described different practices about the advice they gave and how they gave it. Lack of knowledge and skills, both about pregnancy and about patient-physician-pharmacist interaction, were a clear barrier to care for pregnant women in community pharmacies. Conclusion Respondents were comfortable giving advice in clear situations, and found it challenging to do so otherwise. Improving the physician-pharmacist-patient communication environment and providing education and training programmes for pharmacists is necessary to reduce stress and to overcome barriers in advising pregnant women.

Keywords

Advising pregnant women Community pharmacy Content analysis Interviews Lithuania Pharmacy practice Pregnancy 

Notes

Acknowledgments

We thank Professor T. Bondas, the reviewers, and the Santaka Valley for intellectual support.

Funding

Nothing to declare.

Conflicts of interest

Nothing to declare.

References

  1. 1.
    Walsh RA. Effects of maternal smoking on adverse pregnancy outcomes: examination of the criteria of causation. Hum Biol. 1994;66(6):1059–92.PubMedGoogle Scholar
  2. 2.
    Chomitz VR, Cheung LW, Lieberman E. The role of lifestyle in preventing low birth weight. Future Child. 1995;5(1):121–38.PubMedCrossRefGoogle Scholar
  3. 3.
    Bailey BA, Sokol RJ. Pregnancy and alcohol use: evidence and recommendations for prenatal care. Clin Obstet Gynecol. 2008;2(51):436–44.CrossRefGoogle Scholar
  4. 4.
    Norman JE, Reynolds R. The consequences of obesity and excess weight gain in pregnancy. Proc Nutr Soc. 2011;4(70):450–6.CrossRefGoogle Scholar
  5. 5.
    World Health Organization. Jakarta Declaration on Leading Health Promotion into the 21st Century [Internet]. Jakarta: World Health Organization. 1997. (cited 2014 Apr 18). http://www.alliance-healthycities.com/htmls/glossary/pdf/jakarta_declaration_en.pdf.
  6. 6.
    Bradley F, Ashcroft DM, Noyce PR. Integration and differentiation: a conceptual model of general practitioner and community pharmacist collaboration. Res Social Adm Pharm. 2012;8(1):36–461.PubMedCrossRefGoogle Scholar
  7. 7.
    Boonyaprapa S. Self-care in pregnancy and breastfeeding: views of women and community pharmacists in Thailand. Dissertation. Nottingham: University of Nottingham. 2010.Google Scholar
  8. 8.
    Schrempp S, Ryan-Haddad A, Galt KA. Pharmacist counseling of pregnant or lactating women. J Am Pharm Assoc (Wash). 2001;41(6):887–90.Google Scholar
  9. 9.
    de Walle HEK, de Jong-van den Berg LT. Ten years after the Dutch public health campaign on folic acid: the continuing challenge. Eur J Clin Pharmacol. 2008;64(5):539–43.PubMedCentralPubMedCrossRefGoogle Scholar
  10. 10.
    Ballard P, Radley A. Give it up for baby—a smoking cessation intervention for pregnant women in Scotland (Internet). (Scotland): Cases Public Health Commun Mark. 2009;3:147–160 (cited 2014 Apr 18). www.casesjournal.org/volume3.
  11. 11.
    Le Durand M. rôle du pharmacien d’officine dans l’arrêt du tabac pendant la grossesse. J Gynecol Obstet Biol Reprod. 2005;34:336–8.CrossRefGoogle Scholar
  12. 12.
    National Institute for Health and Clinical Excellence. Dietary interventions and physical activity interventions for weight management before, during and after pregnancy PH27 (Internet). London: National Institute for Health and Clinical Excellence. 2010 Jul (cited 2014 Apr 18). http://www.nice.org.uk/nicemedia/live/13056/49926/49926.pdf.
  13. 13.
    Shepherd AA. Nutrition through the life-span. Part 1: preconception, pregnancy and infancy. Br J Nurs. 2008;17(20):1261–8.PubMedCrossRefGoogle Scholar
  14. 14.
    Hughes R, Maher J, Baillie E, Shelton D. Nutrition and physical activity guidance for women in the pre- and post-natal period: a continuing education needs assessment in primary health care. Aust J Prim Health. 2011;17(2):135–41.PubMedCrossRefGoogle Scholar
  15. 15.
    Jaradat N, Sweileh W. Drug Information for community pharmacies: survey on needs and use of drug information with special focus on new information technology (Internet). (Nablus): an-Najah National University. 2003;17:287–300 (cited 2014 Apr 18). http://staff.najah.edu/sites/default/files/2003.1.Drug%20Information%20for%20Community%20Pharmacies%20Survey%20on%20Needs%20and%20Use%20of.pdf.
  16. 16.
    van Trigt AM, Waardenburg CM, Haaijer-Ruskamp FM, de Jong-van den Berg LT. Questions about drugs: How do pregnant women solve them? Pharm World Sci. 1994;16(6):254–9.PubMedCrossRefGoogle Scholar
  17. 17.
    Pellerin P, Elefant E. Un rôle difficile pour le pharmacien d’officine, le conseil en matière de médicament et grossesse. Ann Pharm Fr. 2004;62(4):253–9.PubMedCrossRefGoogle Scholar
  18. 18.
    Hämeen-Anttila K, Jyrkkä J, Enlund H, Nordeng H, Lupattelli A, Kokki E. Medicines information needs during pregnancy: a multinational comparison. BMJ Open 2013;3. doi: 10.1136/bmjopen-2013-002594.
  19. 19.
    Nordeng H, Ystrom E, Einarson A. Perception of risk regarding the use of medications and other exposures during pregnancy. Eur J Clin Pharmacol. 2010;66(2):207–14.PubMedCrossRefGoogle Scholar
  20. 20.
    Law on Pharmacy in Lithuanian Republic. Pub L No. X-709, (Jun 22, 2006).Google Scholar
  21. 21.
    Order of Lithuanian Minister of Health No. V-494 Approval of good pharmacy practice guidances. www.lrs.lt.
  22. 22.
    Atkinson J, Rombaut B. The 2011 PHARMINE report on pharmacy and pharmacy education in the European Union. Pharm Pract (Granada). 2011;9(4):169–87.CrossRefGoogle Scholar
  23. 23.
    Damase-Michel C, Vie C, Lacroix I. Drug counseling in pregnancy: an opinion survey of French community pharmacists. Pharmacoepidemiol Drug Saf. 2004;13(10):711–5.PubMedCrossRefGoogle Scholar
  24. 24.
    Lyszkiewicz DA, Gerichhausen S, Björnsdóttir I, Einarson TR, Koren G, Einarson A. Evidence based information on drug use during pregnancy: a survey of community pharmacists in three countries. Pharm World Sci. 2001;23(2):76–81.PubMedCrossRefGoogle Scholar
  25. 25.
    Anderson C, Rajyaguru R. The role of community pharmacists and medicines counter assistants in health promotion: reflections from a folic acid campaign. Int J Pharm Pract. 2002;1(10):17–22.CrossRefGoogle Scholar
  26. 26.
    Hutschinson S, Mitchell K, Hansford D, Steward D. Community pharmacist’s views and experiences of counter-prescribing in pregnancy. Int J Pharm Pract. 2001;9:15–21.CrossRefGoogle Scholar
  27. 27.
    Grincevičienė Š. The aspects of counseling of pregnant and breastfeeding women about healthy lifestyle and rational use of medications in Lithuanian pharmacies. Dissertation (Kaunas): Lithuanian university of health sciences. 2014.Google Scholar
  28. 28.
    Green J, Thorogood N. Qualitative methods for health research. London: SAGE Publ; 2004.Google Scholar
  29. 29.
    Vaismoradi M, Turunen H, Bondas T. Content analysis and thematic analysis: implications for conducting a qualitative descriptive study. Nurs Health Sci. 2013;15(3):398–405.PubMedCrossRefGoogle Scholar
  30. 30.
    Hsieh HF, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005;15(9):1277–8.PubMedCrossRefGoogle Scholar
  31. 31.
    Elo S, Kyngäs H. The qualitative content analysis process. J Adv Nurs. 2008;62(1):107–1155.PubMedCrossRefGoogle Scholar
  32. 32.
    Sandelowski M. The problem of rigor in qualitative research. ANS Adv Nurs Sci. 1986;8:27–37.PubMedCrossRefGoogle Scholar
  33. 33.
    Bondas T, Hall EOC. Challenges in approaching metasynthesis research. Qual Health Res. 2007;17:113–21.PubMedCrossRefGoogle Scholar
  34. 34.
    Graneheim UH, Lundman B. Qualitative content analysis in nursing research: concepts, procedures and measures to achieve trustworthiness. Nurse Educ Today. 2004;24(2):105–12.PubMedCrossRefGoogle Scholar
  35. 35.
    Lyerly AD, Mitchell LM, Armstrong EM, Harris LH, Kukla R, Kuppermann M, Little MO. Risks, values, and decision making surrounding pregnancy. Obstet Gynecol. 2007;109(4):979–84.PubMedCrossRefGoogle Scholar
  36. 36.
    Holst L, Wright D, Haavik S, Nordeng H. The Use and the User of Herbal Remedies During Pregnancy. J Altern Complement Med. 2009;15(7):787–92.PubMedCrossRefGoogle Scholar
  37. 37.
    Holst L, Wright D, Nordeng H, Haavik S. Use of herbal preparations during pregnancy: focus group discussion among expectant mothers attending a hospital antenatal clinic in Norwich, UK. Complement Ther Clin Pract. 2009;15(4):225–9.PubMedCrossRefGoogle Scholar
  38. 38.
    Low Dog T. The use of botanicals during pregnancy and lactation. Altern Ther Health Med. 2009;15(1):54–8.PubMedGoogle Scholar
  39. 39.
    Jayawickrama HS, Amir LS, Pirotta MV. GPs’ decision-making when prescribing medicines for breastfeeding women: content analysis of a survey. BMC Res Notes. 2010;3:82. doi: 10.1186/1756-0500-3-82.PubMedCentralPubMedCrossRefGoogle Scholar
  40. 40.
    Pucinskiene L. Market of herbal preparations in Lithuania (master theses). (Kaunas): Kaunas Medical University. 2006.Google Scholar
  41. 41.
    Herbal/Traditional Products in Lithuania (Internet). Euromonitor International. 2014. (cited 2014 July 11). http://www.euromonitor.com/herbal-traditional-products-in-lithuania/report.
  42. 42.
    Herbal/Traditional Products in Latvia (Internet). Euromonitor International. 2014. (cited 2014 July 11). http://www.euromonitor.com/herbal-traditional-products-in-latvia/report.
  43. 43.
    Herbal/Traditional Products in Estonia (Internet). Eurominitor International. 2014. (cited 2014 July 11). http://www.euromonitor.com/herbal-traditional-products-in-estonia/report.
  44. 44.
    Herbal/Traditional Products in Poland (Internet). Euromonitor International. 2014. (cited 2014 July 11). http://www.euromonitor.com/herbal-traditional-products-in-poland/report.
  45. 45.
    Herbal/Traditional Products in the Netherlands (Internet). Euromonitor International. 2013. (cited 2014 July 11). http://www.euromonitor.com/herbal-traditional-products-in-the-netherlands/report.
  46. 46.
    Herbal/Traditional Products in Denmark (Internet). Euromonitor International. 2014. (cited 2014 July 11). http://www.euromonitor.com/herbal-traditional-products-in-denmark/report.
  47. 47.
    Herbal/Traditional Products in the United Kingdom (Internet). Euromintor International. 2014. (cited 2014 July 11). http://www.euromonitor.com/herbal-traditional-products-in-the-united-kingdom/report.
  48. 48.
    Echamp EEIG. The Availability of Homeopathic and Anthroposophic Medicinal Products in the EU. Brussels: ECHAMP; 2012.Google Scholar
  49. 49.
    Traulsen JM, Bissell P. Theories of professions and the pharmacist. Int J Pharm Prac. 2004;12:107–14.CrossRefGoogle Scholar
  50. 50.
    Birenbaum A. Reprofessionalisation in pharmacy. Sot Sci Med. 1982;16:871–8.CrossRefGoogle Scholar
  51. 51.
    Makowsky MJ, Guirguis LM, Hughes CA, Sadowski CA, Yuksel N. Factors influencing pharmacists’ adoption of prescribing: qualitative application of the diffusion of innovations theory. Implement Sci. 2013;8:109.PubMedCentralPubMedCrossRefGoogle Scholar
  52. 52.
    Rogers A, Hassell K, Noyce P, Harris J. Advice-giving in community pharmacy: variations between pharmacies in different locations. Health Place. 1998;4(4):365–73.PubMedCrossRefGoogle Scholar
  53. 53.
    Royal Pharmaceutical Society of Great Britain. Medicines, ethics and practice. A guide for pharmacists. 37th ed. London: Royal Pharmaceutical Society. 2013.Google Scholar
  54. 54.
    International Pharmaceutical Federation (FIP). FIP reference paper on the effective utilization of pharmacists in improving maternal, newborn and child health (MNCH) (Internet). (Dublin): FIP Council. 2013. (cited 2014 Apr 21). http://www.fip.org/www/uploads/database_file.php?id=343&table_id=.

Copyright information

© Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie 2015

Authors and Affiliations

  • Švitrigailė Grincevičienė
    • 1
    Email author
  • Loreta Kubilienė
    • 1
  • Kostas Ivanauskas
    • 2
  • Gražina S. Drąsutienė
    • 3
  • Diana Ramašauskaitė
    • 3
  • Jonas Grincevičius
    • 1
  • Jurga Bernatonienė
    • 1
  • Arūnas Savickas
    • 1
  1. 1.Department of Drug Technology and Social Pharmacy, Faculty of PharmacyLithuanian University of Health SciencesKaunasLithuania
  2. 2.Department of Pathology, Forensic Medicine and Pharmacology, Faculty of MedicineVilnius UniversityVilniusLithuania
  3. 3.Clinics of Obstetrics and Gynecology, Faculty of MedicineVilnius UniversityVilniusLithuania

Personalised recommendations